US FDA approves Novo Nordisk's Ozempic to cut risk of diabetic kidney disease progression
Novo's blockbuster diabetes drug Ozempic belongs to a class of drugs known as GLP-1 receptor agonists and has the same active ...
Washington Square News20h
Nationwide dementia cases to double by 2060, NYU Langone researchers find
Researchers from NYU Langone Health found that Americans older than 55 have a 42% risk of developing dementia — nearly twice ...